Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway

Lianglei Jiang,Ting Fang,Tingting Hu,Jun Feng,Pengfei Yan
DOI: https://doi.org/10.1186/s13062-023-00443-0
2024-01-25
Biology Direct
Abstract:Glioma is a brain tumor with high morbidity and mortality rates. Understanding its molecular pathogenesis can provide targets and therapeutic strategies for glioma treatment. miR-338-3p represses tumor growth in several cancers, including glioma. Thus, this study aimed to identify the regulatory effects of miR-338-3p/phosphoinositide 3-kinase (PI3K)/Akt/thrombospondins 1 (THBS1) on glioma progression.
biology
What problem does this paper attempt to address?